In addition to latest news on THEMIS, you can find a selection of our latest clinical risk alerts based on our claims intelligence. These are provided to help keep clinical practice reactive to emerging clinical risk trends, ensuring we can help create a safer clinical world.
TMLEP Member, Justin Stebbing and his team research Baricitinib as a potential treatment for 2019-nCoV
THEMIS’ Lead Clinical Partner, TMLEP, would like to highlight the importance of identifying patients at risk of falls and then managing their time in hospital accordingly.
THEMIS’ Lead Clinical Partner, TMLEP, would like to highlight the importance of recognising red flags of Crohn’s disease, following through with investigations and correctly reviewing tests. Signs of Crohn’s disease must not be ignored, and unexpected results should cause clinicians to consider re-testing or alternate investigations.
TMLEP would highlight the particular litigation risk associated with management of labour and attempted vaginal delivery where abnormalities on CTG trace are not picked up and delivery is not expedited.
THEMIS’ Lead Clinical Partner, TMLEP, would like to highlight how important it is to consider each patient individually and assess the potential risks in light of the individual’s clinical presentation, age, gender and other clinical factors such as test results.
THEMIS’ Lead Clinical Partner, TMLEP, would like to highlight the importance of gaining fully informed consent, whereby the patient is informed of material risks, alternative treatments and the risks of benefits of any alternative risks.
By offering policyholders complimentary access to the very latest healthcare analytics updates from TMLEP, policyholders are kept up to date with access to clinical risk alerts that may impact their practice. As a THEMIS policyholder, this keeps clinical practice responsive to emerging trends that could lead to claims.